Skip to content
Studies have shown that active fund managers routinely underperform the S&P500 index*
Home
Articles
WALL STREET X
Forecasts
Portfolios
Wall Street X
Articles
Forecasts
Portfolios
Search
Results for
{phrase}
(
{results_count}
of
{results_count_total}
)
Displaying
{results_count}
results of
{results_count_total}
BioLineRx Ltd. (NASDAQ: BLRX)
BLRX Stock Predictions and Ratings
WSX Rating:
STRONG SELL
WSX Forecast (1yr):
-7.10%
Analyst Rating:
STRONG BUY
Analyst Forecast (1yr):
296.30%
BLRX Stock Analysis
BLRX
PE Ratio:
BLRX
PEG Ratio:
Not Available
BLRX
Forward EPS Growth (12 month):
0.00%
BLRX
PS Ratio:
10.1
BLRX
PSG Ratio:
Not Available
BLRX
Forward Revenue Growth (12 month):
0.00%
BLRX Articles
No data was found